HCPCS Level IIdrugActive
J2998
Inj plasminogen tvmh 1mg
BETOS: O1E
Effective: 2022-07-01
Description
Injection, plasminogen, human-tvmh, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Ryplazim
Manufacturer
Kedrion Biopharma Inc
HCPCS Dosage
1 MG
Billing Units
68.8000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.